title: Regulation of nuclear factor-kappa B and its inhibitor I kappa B-alpha/MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis.
abstract: Blood monocytes from patients with active tuberculosis are activated in vivo, as evidenced by an increase in the stimulated release of proinflammatory cytokines, such as TNF-alpha, and the spontaneous expression of IL-2R. Further, monocytes from patients demonstrate an augmented susceptibility to a productive infection with HIV-1 in vitro. Mycobacterium tuberculosis and its components are strong signals to activate monocytes to production of cytokines. In this study we examined the basis of activation of monocytes during active tuberculosis and by M. tuberculosis. We found a constitutive degradation of I kappa B-alpha, the major cytoplasmic inhibitor of nuclear factor kappa B (NF-kappa B), in freshly isolated PBMC and monocytes from patients with tuberculosis. In contrast, I kappa B-alpha levels in PBMC and monocytes from healthy subjects or from patients with nontuberculous pulmonary conditions were intact. Further, by electrophoretic mobility shift assay, NF-kappa B was activated in monocytes from tuberculous patients. The expression of I kappa B-alpha gene, which is responsive to activation by NF-kappa B, was up-regulated in PBMC and monocytes from patients, but not in mononuclear cells from healthy subjects or those with nontuberculous lung diseases. By contrast, the expression of other adherence-associated early genes, such as IL-8 and IL-1 beta, was not up-regulated in PBMC of tuberculous patients. Further, M. tuberculosis and its tuberculin, purified protein derivative, induced the degradation of I kappa B-alpha and the expression of I kappa B-alpha mRNA, and purified protein derivative induced the activation of NF-kappa B in monocytes.
authors.affiliation: Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH 44106-4984, USA. zxt2@p.o.cwru.edu
authors.forename: Z
authors.initials: Z
authors.lastname: Toossi
authors.forename: B D
authors.initials: BD
authors.lastname: Hamilton
authors.forename: M H
authors.initials: MH
authors.lastname: Phillips
authors.forename: L E
authors.initials: LE
authors.lastname: Averill
authors.forename: J J
authors.initials: JJ
authors.lastname: Ellner
authors.forename: A
authors.initials: A
authors.lastname: Salvekar
mesh_terms: D004268:DNA-Binding Proteins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D020672:I-kappa B Proteins; D009000:Monocytes / Q000378:metabolism* / Q000382:microbiology*; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis; D014373:Tuberculin / Q000494:pharmacology; D014376:Tuberculosis / Q000276:immunology* / Q000378:metabolism
chemical_list: D004268:DNA-Binding Proteins; D020672:I-kappa B Proteins; D016328:NF-kappa B; C000606204:NFKBIA protein, human; D012333:RNA, Messenger; D014373:Tuberculin; D000072000:NF-KappaB Inhibitor alpha